Tens of thousands of Kaiser Permanente workers in California and Hawaii have gone on strike, demanding safer staffing levels ...

CMS Administrator Dr. Mehmet Oz said that Medicaid’s rapid spending growth is unsustainable and criticized state financing ...

Insurers are cutting coverage for costly GLP-1 weight loss drugs, sparking backlash from advocates who say they're vital for ...

Marlow Hernandez, the founder and former CEO of Cano Health, was set to face a trial over allegations that he fraudulently enriched himself and his family while managing the senior-focused primary ...

Novo Nordisk is paying $240 million up front for global rights to zaltenibart, an Omeros drug that blocks the MASP-3 protein to treat diseases caused by excessive activity of the complement system.

Providence and Humana have teamed up to launch a new data exchange program to improve value-based care. Their project, announced on Monday, seeks to enable secure and standardized clinical data ...

Withings Health Solutions, a company offering health monitoring devices, has added Ilant Health to its Obesity Care Management Partner Ecosystem. It also released its best practices for obesity ...

Healthcare staff members are finding Artera’s AI copilots helpful and easy to use after six months of real-world deployment. Artera, a digital health software company based in Santa Barbara, launched ...

Agentic AI company Hyro closed a $45 million funding round led by Healthier Capital on Tuesday, bringing its fundraising total to $95 million. The New York City-based startup aims to fill healthcare’s ...

A Roche drug that is one of the company’s top cancer products is expanding to autoimmune disease with a new FDA approval in lupus nephritis. The intravenously infused drug, Gazyva, may now be used to ...

In Sir Luke Fildes’ 1891 painting The Doctor, a physician is seen attending to a sick child. The backdrop shows a modest home. The doctor is a figure of undivided attention focused on getting the ...

Patients who want to prevent swelling attacks caused by the rare disease hereditary angioedema can choose from among injectable drugs whose dosing schedules range from every two weeks to every two ...